R&D
June, 2015
Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer
Cancer Discov. 2015 Jun;5(6):598-609
January 22, 2015
December, 2013
Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers
Mol Cancer Ther. 2013 Dec;12(12):2772-81
October, 2013
Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximab
Neoplasia. 2013 Oct;15(10):1196-206
July 28, 2012
November, 2011
Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor
Landes Bioscience, 2011, 3:6, 584-595
October 15, 2011
Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans
J Immunol., 2011, 187:8, 4229-4235